跳至主要内容
临床试验/NCT02241161
NCT02241161已完成3 期

Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations

Derming SRL2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年12月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
Derming SRL
入组人数
20
试验地点
2
主要终点
Clinical evaluation of skin erythema: change from baseline, 1 hour after products application (T1h vs. T0)

研究概览

简要总结

Aim of the study was to evaluate the soothing and re-epithelizing activity of a single application of topical products on experimentally induced erythema by skin stripping on the forearm (volar surface) of 20 healthy volunteers. In particular the activity of the following three cosmetic products and the relative combinations (cream and serum) were assessed: rejuvenating cream, rejuvenating serum, antioxidant serum

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult volunteers of both sexes, aged more than 18 years old
  • Volunteers in a good general state of health in the Investigator opinion
  • Volunteers not taking drugs or undergoing surgical procedure
  • Volunteers who are giving a written informed consent.

排除标准

  • Pregnancy (only for female subjects)
  • lactation (only for female subjects)
  • change in the normal habits in the last month
  • participation in a similar study during the previous month
  • known allergy to one or several ingredients of the products on trial
  • insufficient adhesion to the study protocol
  • dermatological disease
  • clinical and significant skin condition on the test area (e.g. lesions, scars, malformations)
  • endocrine disease
  • hepatic, renal or cardiac disorder
  • topical drugs or surgical procedure on the test areas during the previous 3 months
  • systemic corticosteroids
  • aspirin or non-steroid anti-inflammatory drugs (FANS)
  • diuretic drugs
  • antibiotics and chemotherapics
  • pshycotropic drugs
  • retinoids
  • psoralens
  • cardiologic and vascular drugs

研究组 & 干预措施

plantaricin a - rejuvenating cream

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - rejuvenating cream (Other)

plantaricin a - rejuvenating serum

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - rejuvenating serum (Other)

plantaricin a - antioxidant serum

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - antioxidant serum (Other)

plantaricin a (rejuvenating cream +rejuvenating serum)

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - rejuvenating cream (Other)

plantaricin a (rejuvenating cream +rejuvenating serum)

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - rejuvenating serum (Other)

plantaricin a (rejuvenating cream + antioxidant serum)

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - rejuvenating cream (Other)

plantaricin a (rejuvenating cream + antioxidant serum)

Active Comparator

single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes

干预措施: plantaricin a - antioxidant serum (Other)

结局指标

主要结局

Clinical evaluation of skin erythema: change from baseline, 1 hour after products application (T1h vs. T0)

时间窗: After 1 (T1h) hour from products application

Skin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)

次要结局

  • Clinical evaluation of skin erythema: change from baseline, 6 hours from products application (T6h vs. T0)(After 6 (T6h) hours from products application)
  • Surface microrelief evaluation: change from baseline, 6 hours from products application (T6h vs. T0)(After 6 (T6h) hours from products application)
  • Surface microrelief evaluation: change from baseline, after 24 hours from products application (T24h) hours from products application vs.T0)(After 24 hours (T24h) from products application)
  • Clinical evaluation of skin erythema: change from baseline, after 24 hours from products application (T24h vs. T0)(After 24 (T24h) hours from products application)
  • Optical densitometry: change from baseline, after 1hour from products application (T1h vs. T0)(After 1 (T1h) hour from products application)
  • Optical densitometry: change from baseline, 6 hours from products application (T6h vs. T0)(After 6 (T6h) hours from products application)
  • Optical densitometry: change from baseline, 24 hours from products application (T24h vs.T0)(After 24 (T24h) hours from products application)
  • Surface microrelief evaluation: change from baseline, after 1 hour from products application (T1h vs.T0)(After 1 (Th1) hour from products application)

研究者

发起方
Derming SRL
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验